What do systematic reviews say?

Tinzaparin vs placebo

• Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 253 participants
  Very low